⌘K

Login Start Free

Home/Filings/4/0001209191-23-047575

4//SEC Filing

Suri Anish 4

Accession 0001209191-23-047575

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 4:08 PM ET

Size

4.6 KB

Accession

0001209191-23-047575

Insider Transaction Report

Form 4

Period: 2023-08-25

Cue Biopharma, Inc.CUE

Chief Scientific Officer

Transactions

Purchase
Common Stock
2023-08-25$2.76/sh+4,000$11,040→ 135,638 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001739130

Filing Metadata

Form type: 4
Filed: Aug 28, 8:00 PM ET
Accepted: Aug 29, 4:08 PM ET
Size: 4.6 KB

View on SEC.gov